Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 10 October 2000
Vol. 2000, Issue 53, p. tw5
[DOI: 10.1126/stke.2000.53.tw5]

EDITORS' CHOICE

Neurobiology Smart Benzos in the Age of Anxiety

Benzodiazepines are widely used drugs that enhance inhibitory GABAergic neurotransmission in the central nervous system. This pharmacological profile causes both anxiolytic and sedative effects. In an attempt to better understand the enormous heterogeneity of GABAA receptors, Löw et al. selectively tried to silence specific receptor subunits. They discovered that the α2 subunit of the GABAA receptor mediates the anxiolytic action of benzodiazepines. This finding could lead to the development of new drugs for the treatment of anxiety without the side effects of sedation or motor impairment.

Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J.A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., and Rudolph, U. (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290: 131-134. [Abstract] [Full Text]

Citation: Smart Benzos in the Age of Anxiety. Sci. STKE 2000, tw5 (2000).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882